Jul 2026· Ageing Research Reviews· Vol 121, pp.
103262
· 0 citations· 329 references
Medicine
TL;DR
Whether these potential vitamins have an adjunctive role in delaying or preventing neurodegenerative disease is examined, and optimizing vitamin levels in the body may present a promising, multifaceted role for the management of dementia and related CNS disorders.
Abstract
Dementia, a progressive neurodegenerative disorder, is a primary cause of disability and dependence in the elderly. It has become prevalent worldwide, affecting more than 55 million people. This increasing epidemiological and mechanistic evidence indicates that neuroinflammation, mitochondrial dysfunction, oxidative stress, and neurotransmitter levels are solely related to the disease pathophysiology. Essential micronutrients, such as lipid and water-soluble vitamins, have been identified as potential neuroprotective substances due to their multiple important biochemical roles in maintaining the integrity and functioning of neurons. These oil and water-soluble vitamins (Vitamin A-K) support several important activities of the central nervous system, including the synthesis of neurotransmitters, antioxidant activity, neuroprotective role, and regulation of inflammation, lipid metabolism, and gene expression, all of which are essential in maintaining brain function and neural plasticity. Therefore, the purpose of this review is to critically evaluate the molecular mechanisms by which these vitamins provide neuroprotection as evident in the literature, in both preclinical models and clinical studies. Additionally, this review examines whether these potential vitamins have an adjunctive role in delaying or preventing neurodegenerative disease. Conclusively, optimizing vitamin levels in the body may present a promising, multifaceted role for the management of dementia and related CNS disorders.
How the vitamins’ potential is at stake to reach the clinical perspective is highlighted, along with different strategies to overcome their limitations using novel drug delivery and biomarker-based approaches.
V. Padole, Yogesh A. Kulkarni· Metabolic brain disease· 0 citations
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive dysfunction. Docosahexaenoic acid (DHA), the most abundant ω-3 polyunsaturated fatty acid (PUFA) in the brain, is essential for neuronal structure and function. Although epidemiological studies generally associate higher DHA...
Xin-Hua Li, Yue Jin, Xiao-Yu Li et al.· Pharmacological Research· 0 citations
Vascular dementia (VaD), accounting for up to 20% of dementia cases globally, is primarily driven by chronic cerebral hypoperfusion (CCH), which leads to progressive cognitive impairment. Despite the increasing prevalence of VaD, effective treatments remain limited. Natural products-including herbal formulas, single he...
Jung-Hoon Kim, Yongtaek Oh, Suin Cho· Phytotherapy Research· 0 citations
Alzheimer's disease (AD) is a progressive neurodegenerative disease with amyloid-beta (Aβ) plaques, tau tangles, neuroinflammation, and oxidative stress, and it causes cognitive impairment and neuronal loss. The pharmacological treatment is of limited effectiveness, therefore the interest in novel approaches such as in...
Dnyaneshwar S. Shrirame, Amol A. Tatode, Dhiraj Dabhade et al.· Physiology and Behavior· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.